Stock screener

CURX

Conviction 80HealthcareScan · Tue, Sep 8, 2026
Shooting star
CURX$5.35+5.84%
ResistanceSupportVol 14
63 bars
Vol MA14 166.92K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Curanex Pharmaceuticals IncPharmaceutical Preparationswww.curanexpharma.com
Price5.35
Change+5.84%
Gap+0.89%
Rel volume1.21×
Avg volume172.07K
Avg $ vol165.43K
SMA 203.16
SMA 501.39
SMA 2000.6339
Price vs 50+283.80%
Price vs 200+743.17%
MA stackbullish
50/200 cross
Supertrendup · 4.02
RSI (14)83
MACD hist0.10
MACD cross
Stoch %K / %D82 / 81
ADX (14)56
+DI / −DI62 / 7
RSI divergence
MACD divergence
ATR %+9.55%
ADR %11.47%
52w high9.16
52w low0.1830
From 52w high-41.65%
Above 52w low+2820.77%
New 52w highNo
SqueezeOff
Bollinger width274.35%
%B0.75
Donchian pos81.95%
Donchian high6.48
Donchian low0.1923
AVWAP (52w high)0.8799
vs AVWAP high+507.43%
AVWAP (52w low)0.7536
vs AVWAP low+609.23%
OBV trendUp
Chaikin MF (20)0.25
Today vs 20d1.21×
Avg vol (14d)166.92K
Avg vol (20d)172.07K
Avg $ vol (20d)165.43K
Market cap167.64M
RS 3m (vs SPY)+1562.24%
RS 6m (vs SPY)+1180.32%
RS line new highNo
Trend template7/8
Technical rank99.6
1 week+24.30%
1 month+2641.03%
3 months+1650.74%
6 months+1306.21%
1 year-26.07%
YTD+1351.26%
P/E-39.68
P/B35.02
P/S
P/FCF
EPS-0.1700
Div yield
ROE-88.25%
ROA-83.27%
Debt/Eq
Current45.95
EV/EBITDA
Gross margin
Net margin
Rev growth
EPS growth-1068.75%
Price target
Target upside
Analyst rating
Institutional
Ent. value164.71M
Revenue
Net income-3.29M
Gross profit
Free cash flow
IndustryPharmaceutical Preparations
ExchangeNasdaq
Shares out28.36M
Employees6
ListedTue, Aug 26, 2025
Free float9.11M
Float %32.2%
Short interest24.38K
Days to cover0.2d
Short volume59.8%
Squeeze score18 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA
Conviction80 / 100
Pattern quality
Tech rank99.6 / 100
Group rank
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmShooting star
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in CURX

All disclosures →
No recent disclosed trades by Congress in CURX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CURX

No recent insider (Form 4) filings in CURX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in CURX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.